{
    "id": 25999,
    "fullName": "PBK over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PBK over exp indicates an over expression of the Pbk protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 55872,
        "geneSymbol": "PBK",
        "terms": [
            "PBK",
            "CT84",
            "HEL164",
            "Nori-3",
            "SPK",
            "TOPK"
        ]
    },
    "variant": "over exp",
    "createDate": "01/30/2017",
    "updateDate": "01/30/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9859,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, OTS964 inhibited growth of ovarian cancer cell lines expressing high levels of PBK (TOPK) in culture (PMID: 27334838).",
            "molecularProfile": {
                "id": 27141,
                "profileName": "PBK over exp"
            },
            "therapy": {
                "id": 5259,
                "therapyName": "OTS964",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7683,
                    "pubMedId": 27334838,
                    "title": "T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27334838"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9858,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, OTS514 inhibited growth of ovarian cancer cell lines expressing high levels of PBK (TOPK) in culture and improved survival in a cell line xenograft model (PMID: 27334838).",
            "molecularProfile": {
                "id": 27141,
                "profileName": "PBK over exp"
            },
            "therapy": {
                "id": 5258,
                "therapyName": "OTS514",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7683,
                    "pubMedId": 27334838,
                    "title": "T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27334838"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27141,
            "profileName": "PBK over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}